Y. Shaib, H. El‐Serag (2004)
The epidemiology of cholangiocarcinoma.Seminars in liver disease, 24 2
Shogo Kobayashi, N. Werneburg, S. Bronk, S. Kaufmann, G. Gores (2005)
Interleukin-6 contributes to Mcl-1 up-regulation and TRAIL resistance via an Akt-signaling pathway in cholangiocarcinoma cells.Gastroenterology, 128 7
K. Burak, P. Angulo, T. Pasha, K. Egan, J. Petz, K. Lindor (2004)
Incidence and Risk Factors for Cholangiocarcinoma in Primary Sclerosing CholangitisAmerican Journal of Gastroenterology, 99
T. Todoroki (2000)
Chemotherapy for bile duct carcinoma in the light of adjuvant chemotherapy to surgery.Hepato-gastroenterology, 47 33
Kristen Davies (2020)
GastroenterologyCore Conditions for Medical and Surgical Finals
A. Sirica (2005)
Cholangiocarcinoma: Molecular targeting strategies for chemoprevention and therapyHepatology, 41
S. Ghosh, M. May, E. Kopp (1998)
NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses.Annual review of immunology, 16
A. Pickens, G. Pan, J. McDonald, S. Vickers (1999)
Fas expression prevents cholangiocarcinoma tumor growthJournal of Gastrointestinal Surgery, 3
A. Baldwin (2001)
Series Introduction: The transcription factor NF-κB and human diseaseJournal of Clinical Investigation, 107
P. Taimr, H. Higuchi, E. Kočová, R. Rippe, S. Friedman, G. Gores (2003)
Activated stellate cells express the TRAIL receptor‐2/death receptor‐5 and undergo TRAIL‐mediated apoptosisHepatology, 37
C. Jobin, A. Panja, C. Hellerbrand, Y. Iimuro, J. DiDonato, D. Brenner, R. Sartor (1998)
Inhibition of proinflammatory molecule production by adenovirus-mediated expression of a nuclear factor kappaB super-repressor in human intestinal epithelial cells.Journal of immunology, 160 1
G. Pan, K. O’Rourke, A. Chinnaiyan, R. Gentz, R. Ebner, Jian Ni, V. Dixit (1997)
The Receptor for the Cytotoxic Ligand TRAIL, 276
P. Secchiero, A. Gonelli, E. Carnevale, D. Milani, A. Pandolfi, D. Zella, G. Zauli (2003)
TRAIL Promotes the Survival and Proliferation of Primary Human Vascular Endothelial Cells by Activating the Akt and ERK PathwaysCirculation: Journal of the American Heart Association, 107
H. Ehrhardt, S. Fulda, I. Schmid, J. Hiscott, K. Debatin, I. Jeremias (2003)
TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-κBOncogene, 22
F. Ozawa, H. Friess, J. Kleeff, Z. Xu, A. Zimmermann, M. Sheikh, M. Büchler (2001)
Effects and expression of TRAIL and its apoptosis-promoting receptors in human pancreatic cancer.Cancer letters, 163 1
M. Hejna, M. Pruckmayer, M. Raderer (1998)
The role of chemotherapy and radiation in the management of biliary cancer: a review of the literature.European journal of cancer, 34 7
A. Ashkenazi, R. Pai, S. Fong, Susan Leung, David Lawrence, S. Marsters, Christine Blackie, Ling Chang, Amy McMurtrey, Andrea Hebert, L. Deforge, I. Koumenis, D. Lewis, Louise Harris, J. Bussiere, H. Koeppen, Z. Shahrokh, R. Schwall (1999)
Safety and antitumor activity of recombinant soluble Apo2 ligand.The Journal of clinical investigation, 104 2
K. Tjandra, K. Sharkey, M. Swain (2000)
Progressive development of a Th1‐type hepatic cytokine profile in rats with experimental cholangitisHepatology, 31
W. Fiebiger, W. Scheithauer, T. Traub, A. Kurtaran, C. Gedlicka, G. Kornek, I. Virgolini, M. Raderer (2002)
Absence of Therapeutic Efficacy of the Somatostatin Analogue Lanreotide in Advanced Primary Hepatic Cholangiocellular Cancer and Adenocarcinoma of the Gallbladder Despite In Vivo SomatostatinReceptor ExpressionScandinavian Journal of Gastroenterology, 37
P. Kwo, T. Patel, S. Bronk, G. Gores (1995)
Nuclear serine protease activity contributes to bile acid-induced apoptosis in hepatocytes.The American journal of physiology, 268 4 Pt 1
AJP-Gastrointest Liver Physiol @BULLET
B. Karacay, S. Sanlioglu, T. Griffith, A. Sandler, D. Bonthius (2004)
Inhibition of the NF-κB pathway enhances TRAIL-mediated apoptosis in neuroblastoma cellsCancer Gene Therapy, 11
Yoko Tanimura, T. Kokuryo, Nobuyuki Tsunoda, Y. Yamazaki, K. Oda, Y. Nimura, Naing Mon, Pengyu Huang, Y. Nakanuma, Min-Fu Chen, Y. Jan, T. Yeh, C. Chiu, L. Hsieh, M. Hamaguchi (2005)
Tumor necrosis factor alpha promotes invasiveness of cholangiocarcinoma cells via its receptor, TNFR2.Cancer letters, 219 2
D. Spierings, E. Vries, W. Timens, H. Groen, H. Boezen, S. Jong (2003)
Expression of TRAIL and TRAIL death receptors in stage III non-small cell lung cancer tumors.Clinical cancer research : an official journal of the American Association for Cancer Research, 9 9
H. Dienes, A. Lohse, G. Gerken, P. Schirmacher, H. Gallati, H. Löhr, K. Büschenfelde (1997)
Bile duct epithelia as target cells in primary biliary cirrhosis and primary sclerosing cholangitisVirchows Archiv, 431
A. Baldwin (2001)
Series introduction: the transcription factor NF-kappaB and human disease.The Journal of clinical investigation, 107 1
P. Secchiero, A. Gonelli, E. Carnevale, F. Corallini, C. Rizzardi, S. Zacchigna, M. Melato, G. Zauli (2004)
Evidence for a proangiogenic activity of TNF-related apoptosis-inducing ligand.Neoplasia, 6 4
Young-Soo Kim, R. Schwabe, T. Qian, J. Lemasters, D. Brenner (2002)
TRAIL‐mediated apoptosis requires NF‐kB inhibition and the mitochondrial permeability transition in human hepatoma cellsHepatology, 36
C. Hellerbrand, C. Jobin, Y. Limuro, L. Licato, R. Sartor, D. Brenner (1998)
Inhibition of proinllammatory molecule expression by adenovirus-mediated expression of an NFkB super repressor in activated hepatic stellate cellsGastroenterology, 114
Patrick Legembre, Robert Schickel, B. Barnhart, M. Peter (2004)
Identification of SNF1/AMP Kinase-related Kinase as an NF-κB-regulated Anti-apoptotic Kinase Involved in CD95-induced Motility and Invasiveness*Journal of Biological Chemistry, 279
Denise Harnois, Florencia Que, A. Celli, N. LaRusso, G. Gores (1997)
Bcl‐2 is overexpressed and alters the threshold for apoptosis in a cholangiocarcinoma cell lineHepatology, 26
F. Que, V. Phan, V. Phan, Adrianne Celli, K. Batts, N. LaRusso, G. Gores (1999)
Cholangiocarcinomas express fas ligand and disable the fas receptorHepatology, 30
A. Trauzold, H. Wermann, A. Arlt, S. Schütze, H. Schäfer, S. Oestern, C. Röder, H. Ungefroren, E. Lampe, M. Heinrich, H. Walczak, H. Kalthoff (2001)
CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-κB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cellsOncogene, 20
S. Wiley, K. Schooley, P. Smolak, W. Din, Changwei Huang, J. Nicholl, G. Sutherland, T. Smith, C. Rauch, Craig Smith, R. Goodwin (1995)
Identification and characterization of a new member of the TNF family that induces apoptosis.Immunity, 3 6
C. Rust, L. Karnitz, C. Payá, J. Moscat, R. Simari, G. Gores (2000)
The Bile Acid Taurochenodeoxycholate Activates a Phosphatidylinositol 3-Kinase-dependent Survival Signaling Cascade*The Journal of Biological Chemistry, 275
H. Yano, M. Maruiwa, Akihiro Lemura, A. Mizoguchi, M. Kojiro (1992)
Establishment and characterization of a new human extrahepatic bile duct carcinoma cell line (KMBC)Cancer, 69
H. Walczak, M. Degli-Esposti, Richard Johnson, P. Smolak, Jennifer Waugh, N. Boiani, Martin Timour, M. Gerhart, K. Schooley, Craig Smith, R. Goodwin, C. Rauch (1997)
TRAIL‐R2: a novel apoptosis‐mediating receptor for TRAILThe EMBO Journal, 16
A. Knuth, H. Gabbert, W. Dippold, O. Klein, Walter Sachsse, Dieter Bitter-Suermann, Winfried Prellwitz, K.-H. Büschenfelde (1985)
Biliary adenocarcinoma. Characterisation of three new human tumor cell lines.Journal of hepatology, 1 6
M. Taniai, A. Grambihler, H. Higuchi, N. Werneburg, S. Bronk, Daniel Farrugia, S. Kaufmann, G. Gores (2004)
Mcl-1 Mediates Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Resistance in Human Cholangiocarcinoma CellsCancer Research, 64
H. Inoue, K. Shiraki, T. Yamanaka, S. Ohmori, Takahisa Sakai, M. Deguchi, H. Okano, K. Murata, K. Sugimoto, T. Nakano (2002)
Functional Expression of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand in Human Colonic Adenocarcinoma CellsLaboratory Investigation, 82
Gregory Helbig, K. Christopherson, P. Bhat-Nakshatri, Suresh Kumar, H. Kishimoto, K. Miller, H. Broxmeyer, H. Nakshatri (2003)
NF-κ B Promotes Breast Cancer Cell Migration and Metastasis by Inducing the Expression of the Chemokine Receptor CXCR4*Journal of Biological Chemistry, 278
H. Walczak, Robert Miller, K. Ariail, B. Gliniak, T. Griffith, M. Kubin, Wilson Chin, Jon Jones, A. Woodward, Tiep Le, Craig Smith, P. Smolak, R. Goodwin, C. Rauch, J. Schuh, D. Lynch (1999)
Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivoNature Medicine, 5
Chang Han, Tong Wu (2005)
Cyclooxygenase-2-derived Prostaglandin E2 Promotes Human Cholangiocarcinoma Cell Growth and Invasion through EP1 Receptor-mediated Activation of the Epidermal Growth Factor Receptor and Akt*Journal of Biological Chemistry, 280
R. Pietro, G. Zauli (2004)
Emerging non‐apoptotic functions of tumor necrosis factor‐related apoptosis‐inducing ligand (TRAIL)/Apo2LJournal of Cellular Physiology, 201
C. Hirschberg (2001)
Golgi nucleotide sugar transport and leukocyte adhesion deficiency IIJournal of Clinical Investigation, 108
G. Gores (2003)
Cholangiocarcinoma: Current concepts and insightsHepatology, 37
B. Barnhart, Patrick Legembre, E. Pietras, C. Bubici, G. Franzoso, M. Peter (2004)
CD95 ligand induces motility and invasiveness of apoptosis‐resistant tumor cellsThe EMBO Journal, 23
E. Pikarsky, R. Porat, I. Stein, R. Abramovitch, S. Amit, Shafika Kasem, Elena Gutkovich-Pyest, S. Urieli-Shoval, E. Galun, Y. Ben-Neriah (2004)
NF-kappaB functions as a tumour promoter in inflammation-associated cancer.Nature, 431 7007
A. Franco, Xu Zhang, E. Berkel, J. Sanders, X. Zhang, W. Thomas, T. Nguyen, P. Hersey (2001)
The Role of NF-κB in TNF-Related Apoptosis-Inducing Ligand (TRAIL)-Induced Apoptosis of Melanoma Cells1The Journal of Immunology, 166
G. Alpini, J. McGill, N. LaRusso (2004)
The Pathophysiology of Biliary Epithelia
Y. Iimuro, T. Nishiura, C. Hellerbrand, K. Behrns, R. Schoonhoven, J. Grisham, D. Brenner (1998)
NFkappaB prevents apoptosis and liver dysfunction during liver regeneration.The Journal of clinical investigation, 101 4
E. Pikarsky, R. Porat, I. Stein, R. Abramovitch, S. Amit, Shafika Kasem, Elena Gutkovich-Pyest, S. Urieli-Shoval, E. Galun, Y. Ben-Neriah (2004)
NF-κB functions as a tumour promoter in inflammation-associated cancerNature, 431
Shinji Tanaka, K. Sugimachi, K. Shirabe, M. Shimada, J. Wands, K. Sugimachi (2000)
Expression and Antitumor Effects of TRAIL in Human CholangiocarcinomaHepatology, 32
G. Alpini, J. McGill, N. LaRusso (2002)
The pathobiology of biliary epitheliaHepatology, 35
Yoko Tanimura, T. Kokuryo, Nobuyuki Tsunoda, Y. Yamazaki, K. Oda, Y. Nimura, N. Mon, Pengyu Huang, Y. Nakanuma, Min-Fu Chen, Y. Jan, T. Yeh, C. Chiu, L. Hsieh, M. Hamaguchi (2005)
Tumor necrosis factor α promotes invasiveness of cholangiocarcinoma cells via its receptor, TNFR2Cancer Letters, 219
A. Tolcher, M. Mita, A. Patnaik, E. Rowinsky, A. Corey, M. Fleming, N. Fox, L. Weiner, N. Meropol, R. Cohen (2004)
A phase I and pharmacokinetic study of HGS-ETR1(TRM-1), a human monoclonal agonist-antibody to TRAIL R1, in patients with advanced solid tumors.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 22 14_suppl
Tastuo Murakami, H. Yano, M. Maruiwa, S. Sugihara, M. Kojiro (1987)
Establishment and characterization of a human combined hepatocholangiocarcinoma cell line and its heterologous transplantation in nude miceHepatology, 7
AJP Gastrointestinal and Liver Physiology – Unpaywall
Published: Sep 16, 2005
Access the full text.
Sign up today, get DeepDyve free for 14 days.